Cryoport (CYRX) Misses Q2 EPS by 19c; Offers FY23 Revenue Guidance

Cryoport (NASDAQ: CYRX) reported Q2 EPS of ($0.42), $0.19 worse than the analyst estimate of ($0.23). Revenue for the quarter came in at $57 million versus the consensus estimate of $68.81 million.

GUIDANCE:

Cryoport sees FY2023 revenue of $233-243 million, versus the consensus of $243 million.

For earnings history and earnings-related data on Cryoport (CYRX) click here.

You May Also Be Interested In

• Micron surges 5.5% on blockbuster Anthropic AI deal ahead of earnings
• Ridgepost Capital acquires Stellus Capital Management for $4B AUM
• FirstCash to acquire UK pawn operator Ramsdens for £206 million